Sandoz Announces Capital Markets Day to Highlight Biosimilars Focus

On June 22, 2026, Sandoz Group AG, a leader in affordable medicines, announced plans to hold its capital markets day on September 8, 2026. The event aims to highlight the company's strategies in the biosimilars sector, set to define Sandoz's next decade. It will take place at the London Stock Exchange from 13:30 to 17:00 UK time and will be available via live webcast. Attendance will be by invitation.

Furthermore, Sandoz will host a site visit in Slovenia from November 9-10, 2026, offering deeper insights into its new biosimilars development and supply-chain hub. This event will also be by invitation and there will be no webcast option available.

Sandoz emphasizes that the media release includes forward-looking statements, subject to risks and uncertainties. These may result in outcomes that differ significantly from current expectations. Sandoz's position as a pioneer in affordable medicines and biosimilars remains central to its strategic vision for the future.